Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28386258
Publication Date : //

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Osteopontin (OPN) is highly expressed in demyelinating lesions in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). OPN is cleaved by thrombin into N- (OPN-N) and C-terminal (OPN-C) fragments with different ligands and functions. In EAE, administering recombinant OPN induces relapses, whereas treatment with anti-OPN antibodies ameliorates the disease. Anti-OPN autoantibodies (autoAbs) are spontaneously produced during EAE but have never been detected in MS. The aim of the study was to evaluate anti-OPN autoAbs in the serum of MS patients, correlate them with disease course, and recapitulate the human findings in EAE. We performed ELISA in the serum of 122 patients collected cross-sectionally, and 50 patients with relapsing-remitting (RR) disease collected at diagnosis and followed longitudinally for 10 years. In the cross-sectional patients, the autoAb levels were higher in the RR patients than in the primary- and secondary-progressive MS and healthy control groups, and they were highest in the initial stages of the disease. In the longitudinal group, the levels at diagnosis directly correlated with the number of relapses during the following 10 years. Moreover, in patients with active disease, who underwent disease-modifying treatments, autoAbs were higher than in untreated patients and were associated with low MS severity score. The autoAb displayed neutralizing activity and mainly recognized OPN-C rather than OPN-N. To confirm the clinical effect of these autoAbs , EAE was induced using myelin oligodendrocyte glycoprotein MOG in C57BL/6 mice pre-vaccinated with ovalbumin (OVA)-linked OPN or OVA alone. We then evaluated the titer of antibodies to OPN, the clinical scores and cytokine secretion by spleen lymphocytes. Vaccination significantly induced antibodies against OPN during EAE, decreased disease severity, and the protective effect was correlated with decreased T cell secretion of interleukin 17 and interferon-γ . The best effect was obtained with OPN-C, which induced significantly faster and more complete remission than other OPN vaccines. In conclusion, these data suggest that production of anti-OPN autoAbs may favor remission in both MS and EAE. Novel strategies boosting their levels, such as vaccination or passive immunization, may be proposed as a future strategy in personalized MS therapy.

Authors : Clemente Nausicaa , Comi Cristoforo , Raineri Davide , Cappellano Giuseppe , Vecchio Domizia , Orilieri Elisabetta , Gigliotti Casimiro L , Boggio Elena , Dianzani Chiara , Sorosina Melissa , Martinelli-Boneschi Filippo , Caldano Marzia , Bertolotto Antonio , Ambrogio Luca , Sblattero Daniele , Cena Tiziana , Leone Maurizio , Dianzani Umberto , Chiocchetti Annalisa ,

Related products :

Catalog number Product name Quantity
orb70649 Experimental Autoimmune Encephalomyelitis Complementary peptide This is Experimental Autoimmune Encephalomyelitis Complementary peptide. For research use only. 1 mg
SP-86569-5 Experimental Autoimmune Encephalomyelitis Complementary Peptide (AA: Val-Phe-Ile-Leu-Gly-Pro-Leu-Arg-Leu-Leu-Gly) (MW: 1197.54) 5 mg
SP-86569-5 Experimental Autoimmune Encephalomyelitis Complementary Peptide (AA Val_Phe_Ile_Leu_Gly_Pro_Leu_Arg_Leu_Leu_Gly) (MW 1197.54) 5 mg
E-1002 Experimental Autoimmune Encephalomyelitis Complementary Peptide EAE CP 98 percent C59H100N14O12 CAS: 5mg
86569 Experimental Autoimmune Encephalomyelitis Complementary Peptide Formula C59H100N14O12 Sequence Val_Phe_Ile_Leu_Gly_Pro_Leu_Arg_Leu_Leu_Gly 5mg
H-3584.0001 Experimental Autoimmune Encephalomyelitis Complementary Peptide Salt _ Binding _ Synonym EAE CP SumFormula C59H100N14O12 1.0 mg
H-3584.0005 Experimental Autoimmune Encephalomyelitis Complementary Peptide Salt _ Binding _ Synonym EAE CP SumFormula C59H100N14O12 5.0 mg
EM797 Experimental autoimmune prostatitis antigen 2 Elisa Kit 96T
EIAAB12325 Eapa2,Experimental autoimmune prostatitis antigen 2,Mouse,Mus musculus
EIAAB12324 Eapa2,Experimental autoimmune prostatitis antigen 2 homolog,Rat,Rattus norvegicus
EAPA2_MOUSE ELISA Kit FOR Experimental autoimmune prostatitis antigen 2; organism: Mouse; gene name: Eapa2 96T
EIAAB42183 Eapa1,Experimental autoimmune prostatitis antigen 1,Mouse,Mus musculus,Protein-glutamine gamma-glutamyltransferase 4,TGase-4,Tgm4,Transglutaminase-4
MS3 MS Gene multiple sclerosis
MS1H1_B8S Multiple Sclerosis ,MS1H1,8 SignArrays
MS1H1_R24S Multiple Sclerosis ,MS1H1:24 SignArrays
37-057-232627 Multiple Sclerosis Disease Brain 5 Slides
37-057-230168 Multiple Sclerosis Disease Brain 1 mg
37-057-232109 Multiple Sclerosis Disease Brain 5 Slides
MS1H2_R4S Multiple Sclerosis ,MS1H2:4 SignArrays
MS1H2_R2S Multiple Sclerosis ,MS1H2:2 SignArrays
MS1H1_R8S Multiple Sclerosis ,MS1H1:8 SignArrays
MS1H1_R4S Multiple Sclerosis ,MS1H1:4 SignArrays
MS1H1_B12S Multiple Sclerosis ,MS1H1,12 SignArrays
MS1H1_B24S Multiple Sclerosis ,MS1H1,24 SignArrays
MS1H1_B2S Multiple Sclerosis ,MS1H1,2 SignArrays


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur

Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur